Navigation Links
BioHorizons Announces the Purchase of Implant Logic Systems
Date:4/15/2008

BIRMINGHAM, Ala., and CEDARHURST, N.Y., April 15 /PRNewswire/ -- BioHorizons, Inc. ("BioHorizons") announced today the completion of its purchase of Implant Logic Systems, Ltd. ("ILS"), first announced on January 30, 2008. Implant Logic Systems will operate as a subsidiary of BioHorizons. Steve Boggan, CEO of BioHorizons, commented, "We are excited to expand our product offering to include VIP Virtual Implant Placement planning software and CAD/CAM surgical guides. This acquisition is a key milestone for us as we move the field of implant dentistry into the digital age."

About Implant Logic Systems

Implant Logic Systems is leading the dental implant market with innovative, technologically advanced, surgical tools which significantly improve implant placement quality and accessibility for both doctors and patients. Implant Logic Systems operates in the fields of software technology and medical devices to create a revolutionary implant placement technique. This technique is intended to be less invasive to the patient, shorten recovery time, reduce surgery time by up to 75%, and provide a more accurate implant placement. Implant Logic Systems has experienced rapid growth over the past several years. Implant Logic Systems' computer guided system has proven itself in thousands of clinical surgeries.

http://www.implantlogic.com

About BioHorizons

BioHorizons, Inc. is positioned to become the leader in implant dentistry as the only company with a complete product offering, and it will soon become the first company in the industry to market and brand an integrated solution. The Company will leverage the digital technology experience at its dental laboratories to create a revolutionary business model in the industry, streamlining a highly fragmented process to create efficiency, cost savings, and superior patient outcomes. BioHorizons, Inc. is headquartered in Birmingham, Alabama
'/>"/>

SOURCE BioHorizons, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioHorizons Announces Agreement to Purchase Implant Logic Systems
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
4. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
5. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
6. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
7. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...lth care employment grew by 29,000 jobs in Octobe...istent growth during the U.S. recession. However, ... and health systems are coming closer to having to...dministrators. , (Vocus) ...ued growing in October despite the shedding of job...
(Date:11/24/2009)...if., Nov. 24 NeurogesX, ... focused on developing and commercializing novel p...hony DiTonno, President and Chief Executive Office...r Jaffray Health Care Conference, to be held Decem...York, New York. ,, Mr. DiTonno and Stephen Ghi...
(Date:11/24/2009)...FBI recently approved the Promega PowerPlex 16 HS ... generating DNA records for the National DNA Index...A (PRWEB) -- The FBI recently approved the Promega...ries participating in, or generating DNA records f...rently contains more than seven million profiles a...
(Date:11/24/2009)...ber 24 Shire plc (LSE: S...maceutical company, today,announced that it has su...,velaglucerase alfa, the company,s enzyme replacem...pe 1 Gaucher disease. This is the third marketing,...ubmitted, with previous,submissions in the United ...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4
...18 PharmAthene, Inc.,(Amex: PIP ), a biodefense ... biological and chemical threats, announced today ...ions and an oral presentation on its,Protexia(R) a... the,upcoming HHS Public Health Emergency Medical ...orkshop 2008 / BARDA Industry Day, being held in,A...
... CJPS Enterprises, LLC, the,operator of the Michig...inar schedule available to Michigan companies inte...nd best practices in the healthcare,industry. CJPS...m ) was assigned,this activity by the Michigan Eco...e Life Sciences Pipeline initiative, which was cre...
...18 Human Genome,Sciences, Inc. (Nasdaq: HGSI ) a...obal Life Sciences Conference will be webcast and ... http://www.newscom.com/cgi-bin/prnh/20080416/HGSL... management team will present,a corporate overview...,Time., Investors interested in listening to the ...
Other Biology Technology:PharmAthene to Present Data for Protexia(R) and Valortim(R) at HHS PHEMCE Stakeholders Workshop 2008 2The Michigan Life Sciences Pipeline Announces New Best Practices Seminars Tailored to Michigan Businesses 2
(Date:11/25/2009)...lif.Scientists at the California Institute of Tech...itive emotion-like behavior in the fruit fly, Dro...ay be relevant to the relationship between the neu...activity disorder (ADHD), are described in the Dec...ophila brain contains only about 20,000 neurons a...
(Date:11/25/2009)...Larisch, Head of the Cell Death Research Laborator...gy, has been awarded the prestigious Johnson & Joh...ing the cause of brain cell damage in Parkinson,s ...scientists in support of innovation and excellence... conferred earlier this month at an event at the H...
(Date:11/25/2009)...CAWhen you eat may be just as vital to your health...stitute for Biological Studies. Their experiments ...of thousands of genes in the liverthe body,s metab...ake and not by the body,s circadian clock as conve...mines the activity of a large number of genes comp...
Breaking Biology News(10 mins):Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Feeding the clock 2Feeding the clock 3Sorafenib significantly improves the length of time before breast cancer worsens 58117 1Sorafenib significantly improves the length of time before breast cancer worsens 58117 2World Heart Day 27 September 2009 Work With Heart 58116 1World Heart Day 27 September 2009 Work With Heart 58116 2World Heart Day 27 September 2009 Work With Heart 58116 3World Heart Day 27 September 2009 Work With Heart 58116 4World Heart Day 27 September 2009 Work With Heart 58116 5World Heart Day 27 September 2009 Work With Heart 58116 6First Ever Christopher Reeve Day 289 25 09 29 to be Celebrated with Memorable Chicago Events 58114 1First Ever Christopher Reeve Day 289 25 09 29 to be Celebrated with Memorable Chicago Events 58114 2
...available in German . , Since Monday of this ...inical phase I trial in Neuss, Germany, where it i...PM1002 is based on a vaccine that has been in use ... prevent infection with tuberculosis bacteria much...entific basis for this was laid down by the team w...
...the Environment provides strong evidence that com... costs. The author, Yoram Krozer, General Director...niversities, Institute for Sustainable Innovations...r-reaching, emissions-reduction percentage--as muc... by policy-makers and market interests. , Using ...
... September 11, 2008 People who are asked whether ...d" snack might not follow their intentions when th...tober 2008 issue of the Journal of Nutrition Educ...there is a substantial inconsistency between healt... , Participants were asked about their intentions...
Other Biology News:Clinical trial for new tuberculosis vaccine 2Improving industry efficiency through environmental innovations 2Making snack food choices 2
Hae III (High Concentration) from Takara Mirus Bio
2 ml SmartScan Racks from ABgene
Rabbit Anti-Leptin Receptor Polyclonal Antibody, Unconjugated from BioVision
...wer supply. Capable of producing up to 500 volts a...AGE, SDS-PAGE, DNA or RNA submarine gels as well a... is designed to operate in constant voltage or con...in either mode. The EC135-90 automatically crosses...
Biology Products: